MYGN Related Litigation
-
Result in Myriad Genetics (MYGN) Supreme Court Case Might Not be Binary
-
Myriad Genetics (MYGN) Says U.S. Supreme Court to Hear AMP Case
-
High Court to Review Myriad (MYGN) Patent on Genes
-
Myriad (MYGN) Falls; Generic Drugmakers to Get High Court Review on Patent Suits
-
Supreme Court Ruling Pushes Myriad (MYGN), Genomic (GHDX), Labcorp (LH) Shares Lower
-
Myriad Genetics (MYGN) Shares Surging as US Appeals Court Rules Diagnostic Tests Can Be Patented
Back to MYGN Stock Lookup
